These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 21134077)

  • 21. Role of Fbxw7 expression in hepatocellular carcinoma and adjacent non-tumor liver tissue.
    Imura S; Tovuu LO; Utsunomiya T; Morine Y; Ikemoto T; Arakawa Y; Kanamoto M; Iwahashi S; Saito Y; Takasu C; Yamada S; Ishikawa D; Bando Y; Shimada M
    J Gastroenterol Hepatol; 2014 Oct; 29(10):1822-9. PubMed ID: 24731221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression of Fbxw7 and its correlation with cell proliferation in human hepatocellular carcinoma].
    Zhou ZY; Tu KS; Zhang J; Zheng X; Gao J; Yao YM; Liu QG
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Dec; 28(12):1303-6. PubMed ID: 23232523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of microRNA-223 regulates the ubiquitin ligase FBXW7 in oesophageal squamous cell carcinoma.
    Kurashige J; Watanabe M; Iwatsuki M; Kinoshita K; Saito S; Hiyoshi Y; Kamohara H; Baba Y; Mimori K; Baba H
    Br J Cancer; 2012 Jan; 106(1):182-8. PubMed ID: 22108521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FBXW7/hCDC4 is a general tumor suppressor in human cancer.
    Akhoondi S; Sun D; von der Lehr N; Apostolidou S; Klotz K; Maljukova A; Cepeda D; Fiegl H; Dafou D; Marth C; Mueller-Holzner E; Corcoran M; Dagnell M; Nejad SZ; Nayer BN; Zali MR; Hansson J; Egyhazi S; Petersson F; Sangfelt P; Nordgren H; Grander D; Reed SI; Widschwendter M; Sangfelt O; Spruck C
    Cancer Res; 2007 Oct; 67(19):9006-12. PubMed ID: 17909001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR‑223‑3p regulates cell growth and apoptosis via FBXW7 suggesting an oncogenic role in human testicular germ cell tumors.
    Liu J; Shi H; Li X; Chen G; Larsson C; Lui WO
    Int J Oncol; 2017 Feb; 50(2):356-364. PubMed ID: 28000896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of FBXW7 is related to the susceptibility and poor prognosis of cervical squamous carcinoma.
    Xu Y; Yu J; Liu T; Meng F; Kong D; Lou G
    Biomarkers; 2016; 21(4):379-85. PubMed ID: 26954701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ADA3 regulates normal and tumor mammary epithelial cell proliferation through c-MYC.
    Griffin NI; Sharma G; Zhao X; Mirza S; Srivastava S; Dave BJ; Aleskandarany M; Rakha E; Mohibi S; Band H; Band V
    Breast Cancer Res; 2016 Nov; 18(1):113. PubMed ID: 27852327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic mutational profiling analysis of T cell acute lymphoblastic leukemia reveal mutant FBXW7 as a prognostic indicator for inferior survival.
    Yuan L; Lu L; Yang Y; Sun H; Chen X; Huang Y; Wang X; Zou L; Bao L
    Ann Hematol; 2015 Nov; 94(11):1817-28. PubMed ID: 26341754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-92a is upregulated in cervical cancer and promotes cell proliferation and invasion by targeting FBXW7.
    Zhou C; Shen L; Mao L; Wang B; Li Y; Yu H
    Biochem Biophys Res Commun; 2015 Feb; 458(1):63-9. PubMed ID: 25623537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Fbxw7/hCdc4 tumor suppressor in human cancer.
    Tan Y; Sangfelt O; Spruck C
    Cancer Lett; 2008 Nov; 271(1):1-12. PubMed ID: 18541364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FBXW7 mutation analysis and its correlation with clinicopathological features and prognosis in colorectal cancer patients.
    Chang CC; Lin HH; Lin JK; Lin CC; Lan YT; Wang HS; Yang SH; Chen WS; Lin TC; Jiang JK; Chang SC
    Int J Biol Markers; 2015 Feb; 30(1):e88-95. PubMed ID: 25450649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of CDC4/FBXW7 in gastric carcinoma.
    Milne AN; Leguit R; Corver WE; Morsink FH; Polak M; de Leng WW; Carvalho R; Offerhaus GJ
    Cell Oncol; 2010; 32(5-6):347-59. PubMed ID: 20448329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The sensitivity of gastric cancer to trastuzumab is regulated by the miR-223/FBXW7 pathway.
    Eto K; Iwatsuki M; Watanabe M; Ishimoto T; Ida S; Imamura Y; Iwagami S; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Baba H
    Int J Cancer; 2015 Apr; 136(7):1537-45. PubMed ID: 25159729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FBXW7 is involved in the acquisition of the malignant phenotype in epithelial ovarian tumors.
    Kitade S; Onoyama I; Kobayashi H; Yagi H; Yoshida S; Kato M; Tsunematsu R; Asanoma K; Sonoda K; Wake N; Hata K; Nakayama KI; Kato K
    Cancer Sci; 2016 Oct; 107(10):1399-1405. PubMed ID: 27486687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic susceptibility to the development and progression of breast cancer associated with polymorphism of cell cycle and ubiquitin ligase genes.
    Yu JC; Ding SL; Chang CH; Kuo SH; Chen ST; Hsu GC; Hsu HM; Hou MF; Jung LY; Cheng CW; Wu PE; Shen CY
    Carcinogenesis; 2009 Sep; 30(9):1562-70. PubMed ID: 19587092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of cell-cycle regulatory proteins BUBR1, MAD2, Aurora A, cyclin A and cyclin E in invasive ductal breast carcinomas.
    Du J; Du Q; Zhang Y; Sajdik C; Ruan Y; Tian XX; Fang WG
    Histol Histopathol; 2011 Jun; 26(6):761-8. PubMed ID: 21472690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FBXW7 mutation in adult T-cell and B-cell acute lymphocytic leukemias.
    Song JH; Schnittke N; Zaat A; Walsh CS; Miller CW
    Leuk Res; 2008 Nov; 32(11):1751-5. PubMed ID: 18485478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression profiling reveals transcriptional regulation by Fbxw7/mTOR pathway in radiation-induced mouse thymic lymphomas.
    Snijders AM; Liu Y; Su L; Huang Y; Mao JH
    Oncotarget; 2015 Dec; 6(42):44794-805. PubMed ID: 26575021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FBXW7-mutated colorectal cancer cells exhibit aberrant expression of phosphorylated-p53 at Serine-15.
    Li N; Lorenzi F; Kalakouti E; Normatova M; Babaei-Jadidi R; Tomlinson I; Nateri AS
    Oncotarget; 2015 Apr; 6(11):9240-56. PubMed ID: 25860929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of SIAH2, an ubiquitin E3 ligase, is associated with resistance to endocrine therapy in breast cancer.
    Jansen MP; Ruigrok-Ritstier K; Dorssers LC; van Staveren IL; Look MP; Meijer-van Gelder ME; Sieuwerts AM; Helleman J; Sleijfer S; Klijn JG; Foekens JA; Berns EM
    Breast Cancer Res Treat; 2009 Jul; 116(2):263-71. PubMed ID: 18629630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.